Department of Virology, Viral Respiratory Lab, WHO National Influenza Centre, Psteur Institute of Algeria, Sidi-Fredj, Algiers, Algeria.
Infectious Diseases Modelling Department, EPIMOD, Epidemiology and Modelling of Infectious Diseases, Dompierre sur Veyle, France.
J Med Virol. 2019 Aug;91(8):1394-1399. doi: 10.1002/jmv.25469. Epub 2019 Apr 9.
We report the activity and circulation of influenza viruses in Algeria during four influenza seasons, from a national surveillance study carried out from 2009-2010 to 2012-2013. A total of 2766 samples from in- and outpatients, with no age restriction, were collected. The overall proportion of specimens that tested influenza positive was 46.0%. Overall, 96.6% of influenza A viruses were subtyped, and A/H1 subtypes accounted for 57.3% of influenza A viruses. Influenza A/H1 and A/H3 virus subtypes cocirculated in 2009-2010. In 2010-2011, a high proportion of type B viruses (66.2%) was observed. The subtype H3N2 was identified in 99% of cases typed in 2011-2012. Influenza A/H3N2 and B virus cocirculated in 2012-2013. A remarkably low influenza vaccination rate of 2.4% was observed among all age groups. Antibiotics were prescribed for 926 (41.3%) patients, and no difference was observed between patients with confirmed influenza and patients with influenza-like illness not related to influenza. The burden of influenza is largely undocumented in Algeria and strategies to expand this surveillance across the country are needed. Strategies to increase vaccination coverage are warranted to control and prevent influenza in individuals at risk of complications as well as in the general population.
我们报告了 2009-2010 年至 2012-2013 年四个流感季节期间阿尔及利亚流感病毒的活动和循环情况。这项全国性监测研究共采集了 2766 例门诊和住院患者的样本,无年龄限制。流感阳性样本的总体比例为 46.0%。总体而言,96.6%的甲型流感病毒进行了亚型鉴定,A/H1 亚型占甲型流感病毒的 57.3%。2009-2010 年期间,A/H1 和 A/H3 病毒亚型同时流行。2010-2011 年,B 型病毒比例较高(66.2%)。2011-2012 年鉴定的 99%病例为 H3N2 亚型。2012-2013 年期间,A/H3N2 和 B 型病毒同时流行。所有年龄段的流感疫苗接种率仅为 2.4%。926 例(41.3%)患者开具了抗生素,确诊流感患者和与流感无关的流感样疾病患者之间无差异。阿尔及利亚的流感负担在很大程度上没有记录,需要在全国范围内扩大监测范围。需要采取措施提高疫苗接种覆盖率,以控制和预防有并发症风险的个体以及一般人群中的流感。